Learn about The Research Fund of PHI
and opportunities to
participate in research ...
THE EIGHTH AWARD (2014)
PHI awarded Antonio Toniolo, MD, FAMH, University of Insurbia, Varese, Italy, a two-year grant award of $50,000 each year.
THE SEVENTH AWARD (2013)
PHI awarded $25,000 to a research group from Texas Woman’s University in Houston, Texas.
THE SIXTH AWARDS (2011)
PHI awarded $25,000 each to two research groups. One was from the University of Michigan and the other was from Hadassah Medical Center in Jerusalem.
- Grants Awarded for 2011
- University of Michigan Glutathione Study Lay Abstract
- Hadassah Medical Center Jerusalem Poster
- Update from The PHI Research Fund's 2011 Grantees
- Research Update: Role of Oral Glutathione
THE FIFTH AWARD (2009)
PHI awarded $25,000 to team from University of Insubria, Varese, Italy, led by Antonio Toniolo, MD, PhD, Professor of Medical Microbiology and Virology. The study, Persisting Noninfectious Fragments of Poliovirus in PPS Patients: Virus Detection and Susceptibility to Antiviral Drugs, will complete the sequencing of the genome of persistent fragments of poliovirus strains and compare them to wild-type polioviruses.
- INTERIM REPORT
- FINAL REPORT: Persisting Noninfectious Genome Fragments of Poliovirus in PPS Patients
THE FOURTH AWARD (2007)
PHI Grant Awarded to team at University of Arkansas for Medical Sciences (UAMS) for Pilot Study to Identify PPS Biomarker. The researchers propose to determine whether there is a unique signature, or disease biomarker, in the immune system of individuals with post-polio syndrome (PPS) that would enable a more definitive diagnosis of PPS.
- PRESS RELEASE, December 19, 2006 (pdf)
- INTERIM REPORT
- FINAL REPORT: Regulatory T Cells as a Biomarker of Post-Polio Syndrome
THE THIRD AWARD (2005)
The final report, Timing of Noninvasive Ventilation for Patients with Amyotrophic Lateral Sclerosis, was completed October 2006 by the team of researchers from Johns Hopkins University in Baltimore, Maryland, who conducted a retrospective cohort study of patients with ALS to determine survival time with early use of noninvasive ventilation.
- PRESS RELEASE, December 2004:
PHI Grant Awarded to Johns Hopkins Team to Study Early Use of Noninvasive Ventilation in patients with amyotrophic lateral sclerosis (ALS) and to relate their findings to other neuromuscular diseases including polio and its late effects.
THE SECOND AWARD (2003)
The final report, Women with Polio: Menopause, Late Effects, Life Satisfaction and Emotional Distress, was completed May 14, 2004 by the team of researchers from the University of Michigan in Ann Arbor, Michigan, who conducted a nationwide study of the effects of aging on the lives of polio survivors comparing the problems of men and women.
- PRESS RELEASE, August 26, 2004:
New Study Reports Post-Polio Women Experience Menopause Differently than Nondisabled Peers
- PRESS RELEASE, November 2002
$25,000 Grant Awarded to Study Effects of Aging on Polio Survivors
THE FIRST AWARD (2001)
The final report, Ventilator Users' Perspectives on the Important Elements of Health-Related Quality of Life, presents the perceptions of the health-related quality of life of 26 individuals living in the community (Toronto and Edmonton, Canada) with long-term use of home mechanical ventilation due to neuromuscular disability or traumatic injury.
Participants Wanted: Live in the DC or Johnstown, Pennsylvania area?
Check out this research opportunity funded by the Department of Defense.
Additional contributions are needed to increase
of The Research Fund so larger grants can be awarded.
"Contributing to the Fund is an excellent way to honor loved ones,"
says Joan Headley, Executive Director of PHI & IVUN.
Support The Research Fund and/or the vital work of PHI (tax-deductible) on our secure shopping cart, or download a Donation Form (pdf) to print and mail, call 314-534-0475, or use PayPal to firstname.lastname@example.org.
To offer "Gifts-in-Kind" sponsorships, or to ask about the needs of PHI, contact
Joan L. Headley, Executive Director, at 314-534-0475 or email@example.com.